GLP-1 use may prevent recurrent arrhythmia events for patients with diabetes, obesity
Healio: Varun Sundaram, associate professor of medicine, shared his thoughts on a study that demonstrated how GLP-1 use dramatically reduced the incidence of atrial fibrillation-related events in patients with diabetes, atrial fibrillation, and obesity, with those with extreme obesity benefiting the most.
